Dec 2018

Supply Chain & Regulatory Due Diligence on a $25M Investment in Cold Chain Logistics & Technology

Petrichor Cryoport

PharmaBioSource provided consulting services to Petrichor Healthcare Capital Management to support its $25M investment in Cryoport.

  • Service: Due Diligence
  • Sector: Technology
  • Sub-sector: Pharmaceutical Cold Chain Logistics
  • Engagement Type: Consulting

PharmaBioSource provided due diligence support to Petrichor’s investment in Cryoport, a cold chain logistics company which offers cold, ultra-cold and cryogenic shipping and storage of high value pharmaceutical and biotech products.

PharmaBioSource’s services included a study of the competitive landscape for cold chain logistics, an assessment of Cryoport’s customer base and an evaluation of its facilities in Irvine, CA.

Transactions

View All Transactions
Dec 2023

PharmaBioSource Advises Lubrizol on the Sale of Particle Sciences to Agno Pharma

Read More
Nov 2023

Indivior Acquires Sagent Pharmaceutical's Sterile Injectable Fill / Finish Manufacturing Facility in Raleigh, North Carolina

Read More
Jan 2022

Sale of Sterile Fill / Finish & Topical Liquids & Creams Manufacturing & Packaging Facility in New Jersey for $27M

Read More
Jul 2020

Sale of an Oral Solids and Liquids Manufacturing Operation in the U.S.

Read More
Aug 2019

Sale of Soft Gel Development and Manufacturing Assets and Facility Lease

Read More
Jun 2019

Lease of Small Molecule API Research and Development Facility with Kilo Labs and Pilot Plant

Read More
Jun 2019

Divestment of a Small Molecule API Manufacturing Site in Lodi, Italy

Read More
Jun 2019

Divestment of a Sterile Fill / Finish Manufacturing Facility & CMO Business in León, Spain

Read More
Jun 2019

Lease of Cell & Gene Therapy Clinical R&D Laboratories and Manufacturing

Read More